标题
Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy
作者
关键词
-
出版物
Cells
Volume 11, Issue 21, Pages 3336
出版商
MDPI AG
发表日期
2022-10-24
DOI
10.3390/cells11213336
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Scoparone alleviates Ang II‐induced pathological myocardial hypertrophy in mice by inhibiting oxidative stress
- (2021) Linmao Lyu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Role of PI3-Kinase in Angiotensin II-Induced Cardiac Hypertrophy: Class I Versus Class III
- (2021) Tiecheng Zhong et al. Frontiers in Pharmacology
- An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update
- (2021) Kanika Verma et al. Frontiers in Pharmacology
- Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure
- (2021) Anureet K. Shah et al. Antioxidants
- Ca 2+ -Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production
- (2020) Guo-Jun Zhao et al. HYPERTENSION
- NRF2 in Cardiovascular Diseases: a Ray of Hope!
- (2020) Ruju Vashi et al. Journal of Cardiovascular Translational Research
- Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6/STAT3-dependent inflammation
- (2019) Dandan Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- NOX5: Molecular biology and pathophysiology
- (2019) Rhian M. Touyz et al. EXPERIMENTAL PHYSIOLOGY
- Angiotensin-converting-enzyme inhibitors in hemodynamic congestion: a meta-analysis of early studies
- (2019) Alexander Jobs et al. Clinical Research in Cardiology
- Angiotensin II-induced Hypertension and Cardiac Hypertrophy are Differentially Mediated by TLR3- and TLR4-Dependent Pathways
- (2019) Madhu V Singh et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway
- (2019) Pei Nie et al. Oxidative Medicine and Cellular Longevity
- Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats
- (2019) Rong-Hua Zheng et al. Drug Design Development and Therapy
- NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
- (2019) Yixuan Zhang et al. Nature Reviews Cardiology
- Mechanisms for the transition from physiological to pathological cardiac hypertrophy
- (2019) Christopher J. Oldfield et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy
- (2019) Wei-Wei Zhang et al. MOLECULAR BIOLOGY REPORTS
- Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
- (2018) Steven J. Forrester et al. PHYSIOLOGICAL REVIEWS
- The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
- (2018) Robson Augusto Souza Santos et al. PHYSIOLOGICAL REVIEWS
- Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats
- (2018) Giovanna Castoldi et al. ACTA DIABETOLOGICA
- Angiotensin II requires an intact cardiac thyrotropin-releasing hormone (TRH) system to induce cardiac hypertrophy in mouse
- (2018) Ludmila Soledad Peres Diaz et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Angiotensin II upregulates cyclophilin A by enhancing ROS production in rat cardiomyocytes
- (2018) Hangyu Tian et al. Molecular Medicine Reports
- CD38 promotes angiotensin II-induced cardiac hypertrophy
- (2017) Xiao-Hui Guan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy
- (2017) Chih-Yang Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes
- (2017) Ana Paula Cremasco Takano et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 Receptor
- (2017) U. Muscha Steckelings et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure
- (2016) Vaibhav B. Patel et al. CIRCULATION RESEARCH
- Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease
- (2016) B. S. M. Chow et al. CLINICAL SCIENCE
- Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion
- (2016) Yong Seon Choi et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1–7)-Mas axes in pressure overload-induced cardiac remodeling in male mice
- (2016) Xingxu Wang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Physiological and pathological cardiac hypertrophy
- (2016) Ippei Shimizu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy
- (2016) Lichun Zhou et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Specific Mechanisms Underlying Right Heart Failure: The Missing Upregulation of Superoxide Dismutase-2 and Its Decisive Role in Antioxidative Defense
- (2015) Rolf Schreckenberg et al. ANTIOXIDANTS & REDOX SIGNALING
- Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
- (2015) Yow Keat Tham et al. ARCHIVES OF TOXICOLOGY
- NADPH Oxidase 4 Induces Cardiac Fibrosis and Hypertrophy Through Activating Akt/mTOR and NF B Signaling Pathways
- (2015) Q. D. Zhao et al. CIRCULATION
- Regulation of Signal Transduction by Reactive Oxygen Species in the Cardiovascular System
- (2015) D. I. Brown et al. CIRCULATION RESEARCH
- Angiotensin type 2 receptors: blood pressure regulation and end organ damage
- (2015) Colin Sumners et al. CURRENT OPINION IN PHARMACOLOGY
- Angiotensin Ⅱ Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4
- (2015) Susumu Matsuda et al. Journal of Atherosclerosis and Thrombosis
- AT2 Receptor Activities and Pathophysiological Implications
- (2015) Luis C. Matavelli et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway
- (2015) Li Lin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP
- (2015) Nan Li et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- From Contractile Enhancement to Pathological Hypertrophy
- (2015) Tetsuro Ago et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ANG II promotes IGF-IIR expression and cardiomyocyte apoptosis by inhibiting HSF1 via JNK activation and SIRT1 degradation
- (2014) C-Y Huang et al. CELL DEATH AND DIFFERENTIATION
- Angiotensin-(1–7) and angiotensin-(1–9): function in cardiac and vascular remodelling
- (2014) Clare A. McKinney et al. CLINICAL SCIENCE
- Closed-chest small animal model to study myocardial infarction in an MRI environment in real time
- (2014) Darach O h-Ici et al. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
- Redox regulation of cardiac hypertrophy
- (2014) Can M. Sag et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases
- (2013) Erin G. Rosenbaugh et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- Nox2-Induced Production of Mitochondrial Superoxide in Angiotensin II-Mediated Endothelial Oxidative Stress and Hypertension
- (2013) Sergey I. Dikalov et al. ANTIOXIDANTS & REDOX SIGNALING
- ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
- (2013) AC Simões e Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Redox signaling in cardiovascular health and disease
- (2013) Nageswara R. Madamanchi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Upregulation of M3 muscarinic receptor inhibits cardiac hypertrophy induced by angiotensin II
- (2013) Yan Liu et al. Journal of Translational Medicine
- Redox Signaling in Cardiac Physiology and Pathology
- (2012) Joseph R. Burgoyne et al. CIRCULATION RESEARCH
- Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System
- (2012) Bernard Lassègue et al. CIRCULATION RESEARCH
- Agonist-Induced Hypertrophy and Diastolic Dysfunction Are Associated With Selective Reduction in Glucose Oxidation
- (2012) Jun Mori et al. Circulation-Heart Failure
- Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin–angiotensin system
- (2012) Robson A S Santos et al. JOURNAL OF ENDOCRINOLOGY
- Molecular basis of physiological heart growth: fundamental concepts and new players
- (2012) Marjorie Maillet et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function
- (2012) Shetal H. Padia et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Angiotensin-(1-7)-Mediated Signaling in Cardiomyocytes
- (2012) Enéas R. M. Gomes et al. International Journal of Hypertension
- ROS-induced ROS release in vascular biology: redox-redox signaling
- (2011) Natalya S. Zinkevich et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Angiotensin II Type-1 Receptor-JAK/STAT Pathway Mediates the Induction of Visfatin in Angiotensin II-Induced Cardiomyocyte Hypertrophy
- (2011) Liang Chang et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies
- (2011) Alexander Sirker et al. BASIC RESEARCH IN CARDIOLOGY
- Up-regulation of p27kip1 contributes to Nrf2-mediated protection against angiotensin II-induced cardiac hypertrophy
- (2011) Jinqing Li et al. CARDIOVASCULAR RESEARCH
- Mitochondrial Oxidative Stress Mediates Angiotensin II–Induced Cardiac Hypertrophy and Gαq Overexpression–Induced Heart Failure
- (2011) Dao-Fu Dai et al. CIRCULATION RESEARCH
- Regulation of myocardial growth and death by NADPH oxidase
- (2011) Yasuhiro Maejima et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy
- (2011) Prakashsrinivasan Shanmugam et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Targeting Mitochondrial Oxidative Stress in Heart Failure
- (2011) Christoph Maack et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mitochondria-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current
- (2010) Jing-Xiang Yin et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Blockage of Angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation
- (2010) M. S. Carneiro-Ramos et al. BASIC RESEARCH IN CARDIOLOGY
- Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway
- (2010) Ning Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Angiotensin II receptors and drug discovery in cardiovascular disease
- (2010) Chiranjib Dasgupta et al. DRUG DISCOVERY TODAY
- Reactive oxygen species and vascular biology: implications in human hypertension
- (2010) Rhian M Touyz et al. HYPERTENSION RESEARCH
- Curcumin Reduces Angiotensin II–mediated Cardiomyocyte Growth via LOX-1 Inhibition
- (2010) Bum-Yong Kang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
- (2010) Bianca C. Bernardo et al. PHARMACOLOGY & THERAPEUTICS
- Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress
- (2009) Jinqing Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3β/mTOR signaling pathway
- (2009) Gabriela Placoná Diniz et al. BASIC RESEARCH IN CARDIOLOGY
- Targeting the Nrf2 pathway against cardiovascular disease
- (2009) Jinqing Li et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Attenuation of Angiotensin II–Induced Vascular Dysfunction and Hypertension by Overexpression of Thioredoxin 2
- (2009) Julian D. Widder et al. HYPERTENSION
- Molecular targets and regulators of cardiac hypertrophy
- (2009) Agrawal Rohini et al. PHARMACOLOGICAL RESEARCH
- Management of Hypertension in Patients with Cardiac Disease: Use of Renin-Angiotensin Blocking Agents
- (2008) L. Michael Prisant AMERICAN JOURNAL OF MEDICINE
- Redox Signaling, Vascular Function, and Hypertension
- (2008) Moo Yeol Lee et al. ANTIOXIDANTS & REDOX SIGNALING
- Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart
- (2008) Chantal Mercure et al. CIRCULATION RESEARCH
- Involvement of Nox2 NADPH Oxidase in Adverse Cardiac Remodeling After Myocardial Infarction
- (2008) Yee H. Looi et al. HYPERTENSION
- Involvement of Tumor Necrosis Factor-α in Angiotensin II–Mediated Effects on Salt Appetite, Hypertension, and Cardiac Hypertrophy
- (2008) Srinivas Sriramula et al. HYPERTENSION
- Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes
- (2008) Marco F. Dias-Peixoto et al. HYPERTENSION
- Electrocardiographic Left Ventricular Hypertrophy Regression Induced by an Angiotensin Receptor Blocker-Based Regimen in Hypertensive Patients With the Metabolic Syndrome: Data From the SARA Study
- (2008) Carlos Escobar et al. Journal of Clinical Hypertension
- Angiotensin II: A hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks
- (2008) K.-D. Schlüter et al. PHARMACOLOGY & THERAPEUTICS
- The Wnt/frizzled/GSK-3β pathway: a novel therapeutic target for cardiac hypertrophy
- (2008) W BLANKESTEIJN et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Molecular Mechanisms of Angiotensin II–Mediated Mitochondrial Dysfunction
- (2007) Abdulrahman K. Doughan et al. CIRCULATION RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started